Overview
Varvara Brilliantova practices practicing medicine in Moscow, Russian Federation.
Ms. Brilliantova is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Nijmegen Breakage Syndrome, Reticulohistiocytoma, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Varvara V. Brilliantova
Is Varvara V. Brilliantova a top-rated expert for Hemophagocytic Lymphohistiocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Varvara V. Brilliantova is classified as an Advanced expert for Hemophagocytic Lymphohistiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Varvara V. Brilliantova participate in research or clinical trials?
Yes. Varvara V. Brilliantova has published 11 articles and abstracts on conditions like Hemophagocytic Lymphohistiocytosis. You can view a list of Varvara V. Brilliantova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hemophagocytic LymphohistiocytosisMs. Brilliantova isAdvanced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisMs. Brilliantova isAdvanced. Learn about Histiocytosis.
- Nijmegen Breakage SyndromeMs. Brilliantova isAdvanced. Learn about Nijmegen Breakage Syndrome.
- Non-Langerhans-Cell HistiocytosisMs. Brilliantova isAdvanced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaMs. Brilliantova isAdvanced. Learn about Reticulohistiocytoma.
- Experienced
- Aplasia Cutis CongenitaMs. Brilliantova isExperienced. Learn about Aplasia Cutis Congenita.
- Atelosteogenesis Type 1Ms. Brilliantova isExperienced. Learn about Atelosteogenesis Type 1.
- Bone Marrow TransplantMs. Brilliantova isExperienced. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)Ms. Brilliantova isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Clouston SyndromeMs. Brilliantova isExperienced. Learn about Clouston Syndrome.
- Ectodermal DysplasiasMs. Brilliantova isExperienced. Learn about Ectodermal Dysplasias.
- Graft Versus Host Disease (GvHD)Ms. Brilliantova isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Paroxysmal Nocturnal Hemoglobinuria (PNH)Ms. Brilliantova isExperienced. Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).
- Primary Immunodeficiency (PID)Ms. Brilliantova isExperienced. Learn about Primary Immunodeficiency (PID).
- SchizophreniaMs. Brilliantova isExperienced. Learn about Schizophrenia.